Почетна › Аутоимуне болести › Тексас › Houston
Kliničke studije za Аутоимуне болести u gradu Houston, TX
Jedna studija za Аутоимуне болести traži učesnike na lokaciji u gradu Houston ili u blizini. Otvorite je da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Тражи се учесникФаза 3
- Site Number - 1057, Houston
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Тражи се учесникФаза 2/3
- Houston Methodist Hospital - Accepting Adult Patients, Houston
- University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Тражи се учесникФаза 2
- University of Texas - Houston, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Тражи се учесникОпсервациона студија
- M D Anderson Cancer Center, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Тражи се учесникФаза 1
- UT MD Anderson Cancer Center, Houston
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Тражи се учесникФаза 3
- Texas Children's Hospital/ Baylor College of Medicine, Houston
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Тражи се учесникФаза 3
- Abigail Neiman MD PA, Houston
- Novel Research LLC, Bellaire · 7 ми удаљено
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Тражи се учесникФаза 3
- Baylor College of Medicine, Houston
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Тражи се учесникФаза 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Тражи се учесникФаза 2
- Jade Clinical Site, Houston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Тражи се учесникФаза 3
- Baylor College of Medicine, Houston
Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases
Тражи се учесникФаза 1
- Houston Methodist Hospital, Houston
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
Тражи се учесникФаза 1/2
- Baylor College of Medicine Neurology Department, Houston
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Тражи се учесникФаза 1/2
- MD Anderson Texas Medical Center, Houston
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Тражи се учесникФаза 1/2
- University of Texas MD Anderson Cancer Center, Houston
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Тражи се учесникФаза 2
- MD Anderson Cancer Center, Houston
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Тражи се учесникФаза 3
- GSK Investigational Site, Houston
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Тражи се учесникФаза 3
- Nephro Asso North Illinois Indiana, Houston
Study of BHV-1300 in Graves' Disease
Тражи се учесникФаза 1
- Site-106, Houston
- Site-101, Houston
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Тражи се учесникФаза 2/3
- Houston Methodist Hospital, Houston
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Тражи се учесникОпсервациона студија
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital - Baylor Medical Center, Houston
Studije za Аутоимуне болести u drugim gradovima
- Washington, DC19 студија
- New York City, NY19 студија
- Philadelphia, PA17 студија
- Durham, NC15 студија
- Boston, MA13 студија
- Chicago, IL13 студија
- Los Angeles, CA12 студија
- Atlanta, GA9 студија
- Dallas, TX9 студија
- Miami, FL8 студија
- Milwaukee, WI8 студија
- Cleveland, OH8 студија
Ostale studije u gradu Houston
- Немалоклетни карцином плућа143 студија
- Рак дојке126 студија
- Рак (све врсте)124 студија
- Колоректални карцином101 студија
- Метастатски карцином100 студија
- Рак јајника90 студија
- Akutna mijeloidna leukemija88 студија
- Рак плућа78 студија
- Рак простате73 студија
- Карцином ендометријума69 студија
- Меланом61 студија
- Рак панкреаса59 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.